Verition Fund Management
SLXP

Verition Fund Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Verition Fund Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,706
Closed -$295K – 809
2015
Q1 		$295K Buy
+1,706
New +$250K 0.03% 205
2014
Q4 		– Sell
-2,175
Closed -$340K – 818
2014
Q3 		$340K Sell
2,175
-9,064
-81% -$1.31M 0.05% 353
2014
Q2 		$1.39M Buy
+11,239
New +$1.24M 0.15% 89

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Verition Fund Management's SLXP Position: Q2 2015 in Review

Verition Fund Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,706 shares — an estimated $295K sold.

Verition Fund Management first reported a position in SLXP in Q2 2014 and held it in 3 quarters. The position peaked at $1.39M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Verition Fund Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Verition Fund Management sold 1,706 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $295K.
  • Verition Fund Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 3 quarters.
  • Verition Fund Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.39M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Verition Fund Management's 13F filing for Q2 2015, filed 14 Aug 2015.